drugset
drugset / Trial / NCT03925701

Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

NCT03925701 ↗

Phase 3 Recruiting 120 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.

Timeline

Start
2019-04-01
Primary completion
2028-12
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule — —
Subject Vildagliptin Other / unclassified 50 mg —

Indications

No indication recorded.